Soleus Capital Management, L.P.

Source: SEC Form 13F · as of Mar 2026

Soleus Capital Management, L.P. holds 59 biotech & pharma companies tracked by BioSniper, totaling $1.04B in value as of Mar 2026 (SEC Form 13F).

Companies held

59

Total value held

$1.04B

CompanySharesValue
UTHRUNITED THERAPEUTICS Corp187,187$111.0M
PRAXPraxis Precision Medicines, Inc.330,517$106.5M
ALKSAlkermes plc.1,970,864$69.7M
GMEDGlobus Medical Inc.729,467$62.9M
TWSTTwist Bioscience Corp1,226,629$58.3M
EWTXEdgewise Therapeutics, Inc.1,449,915$45.7M
ALNYALNYLAM PHARMACEUTICALS, INC.131,650$43.6M
SNDXSyndax Pharmaceuticals Inc1,726,908$40.3M
INDVIndivior Pharmaceuticals, Inc.1,274,000$38.8M
MIRMMirum Pharmaceuticals, Inc.400,306$37.0M
BMRNBIOMARIN PHARMACEUTICAL INC650,572$36.8M
INSPInspire Medical Systems Inc.576,299$29.7M
KNSAKiniksa Pharmaceuticals International, plc521,353$25.1M
MRKMerck & Co., Inc.203,000$24.4M
PCVXVaxcyte, Inc.385,472$22.4M
ICLRICON plc192,000$21.2M
PHVSPharvaris N.V.702,052$19.8M
TRVITrevi Therapeutics, Inc.1,620,000$19.3M
VIRVir Biotechnology, Inc.2,002,000$17.9M
XENEXenon Pharmaceuticals Inc.292,000$17.0M
TVTXTravere Therapeutics, Inc.546,000$16.2M
NRIXNurix Therapeutics, Inc.938,163$14.5M
URGNUroGen Pharma Ltd.727,000$13.1M
SIONSionna Therapeutics, Inc.293,500$11.8M
CORTCORCEPT THERAPEUTICS INC285,531$11.5M
JBIOJade Biosciences, Inc.796,744$11.2M
RCUSArcus Biosciences, Inc.451,983$9.8M
TNGXTango Therapeutics, Inc.450,000$9.4M
ELVNEnliven Therapeutics, Inc.230,869$9.1M
INBXInhibrx Biosciences, Inc.131,000$8.8M
SEPNSepterna, Inc.275,000$6.6M
AVTXAvalo Therapeutics, Inc.441,978$6.6M
RLMDRELMADA THERAPEUTICS, INC.842,106$5.9M
CGEMCullinan Therapeutics, Inc.410,200$5.8M
IMVTImmunovant, Inc.230,000$5.7M
MBXMBX Biosciences, Inc.178,897$5.3M
LRMRLarimar Therapeutics, Inc.1,066,960$4.8M
ETONEton Pharmaceuticals, Inc.166,381$4.1M
SABSSAB BIOTHERAPEUTICS, INC.1,050,000$4.0M
PRCTPROCEPT BioRobotics Corporation160,000$4.0M
GPCRStructure Therapeutics Inc.80,000$3.9M
TECXTectonic Therapeutic, Inc.121,684$3.8M
IOVAIOVANCE BIOTHERAPEUTICS, INC.1,000,000$3.5M
ARGXARGENX SE3,500$2.6M
KPTIKaryopharm Therapeutics Inc.440,000$2.5M
ARWRARROWHEAD PHARMACEUTICALS, INC.28,479$1.8M
INSMINSMED Inc10,250$1.7M
CTMXCytomX Therapeutics, Inc.300,000$1.4M
CGONCG Oncology, Inc.20,000$1.4M
NEONeoGenomics Inc.175,000$1.3M
COGTCogent Biosciences, Inc.10,000$385K
TYRATyra Biosciences, Inc.10,000$383K
ANABANAPTYSBIO, INC6,000$333K
RAPPRapport Therapeutics, Inc.10,000$313K
RIGLRIGEL PHARMACEUTICALS INC10,000$270K
ZYMEZymeworks Inc.10,000$250K
LBRXLB PHARMACEUTICALS INC10,000$247K
ORKAOruka Therapeutics, Inc.5,000$245K
JSPRJasper Therapeutics Inc.276,312$242K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Soleus Capital Management, L.P. — Biotech 13F Holdings & Portfolio | BioSniper